Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα)-Reference-Cited by-同舟云学术

Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα)

Published:1994-06-01 Issue:5 Volume:57 Page:656-663
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Renard N.,Liénard D.,Lespagnard L.,Eggermont A.,Heimann R.,Lejeune F.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.

2. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines

3. The eortc melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study

4. An endotoxin-induced serum factor that causes necrosis of tumors.

5. and and , Endothelial activation. Its role in inflammatory and immune reaction. In: and (eds.) Endothelia cell biology, pp. 335–347. Plenum, New York (1988).

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions;Antibodies;2023-04-14

2. Isolated limb perfusion for soft tissue sarcoma: Current practices and future directions. A survey of experts and a review of literature;Cancer Treatment Reviews;2020-08

3. TAK1 Prevents Endothelial Apoptosis and Maintains Vascular Integrity;Developmental Cell;2019-01

4. The cybernetics of TNF: Old views and newer ones;Seminars in Cell & Developmental Biology;2016-02

5. The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms;OncoImmunology;2015-08-28